A quantitative treatment planning study evaluating the potential of dose escalation in conformal radiotherapy of the oesophagus

被引:127
|
作者
Bedford, JL
Viviers, L
Guzel, Z
Childs, PJ
Webb, S
Tait, DM
机构
[1] Inst Canc Res, Joint Dept Phys, Sutton SM2 5PT, Surrey, England
[2] Royal Marsden NHS Trust, Sutton SM2 5PT, Surrey, England
[3] Inst Canc Res, Acad Unit Radiotherapy & Oncol, Sutton SM2 5PT, Surrey, England
[4] Ctr Canc, Gastrointestinal Tract Canc Clin, PL-02781 Warsaw, Poland
关键词
conformal radiotherapy; dose escalation; tumour control probability; normal tissue complication probability; oesophagus; lung;
D O I
10.1016/S0167-8140(00)00258-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: This study aims to evaluate the reduction in radiation dose to normal thoracic structures through the use of conformal radiotherapy techniques in the treatment of oesophageal cancer, and to quantify the resultant potential for dose escalation. Materials and methods: Three different CT-derived treatment plans were created and compared for each of ten patients. A two-phase treatment with conventional straight-edged fields and standard blocks (CV2), a two-phase conformal plan (CF2), and a three-phase conformal plan where the third phase was delivered to the gross tumour only (CF3), were considered for each patient. Escalated dose levels were determined for techniques CF2 and CF3, which by virtue of the conformal field shaping, did not increase the mean lung dose. The resulting increase in tumour control probability (TCP) was estimated. Results: A two-phase conformal technique (CF2) reduced the volume of lung irradiated to 18 Gy from 19.7 +/- 11.8 (1 SD) to 17.1 +/- 12.3% (P = 0.004), and reduced the normal tissue complication probability (NTCP) from 2.4 +/- 4.0 to 0.7 +/- 1.6% (P = 0.02) for a standard prescribed dose of 55 Gy. Consequently, technique CF2 permitted a target dose of 59.1 +/- 3.2 Gy without increasing the mean lung dose. Technique CF3 facilitated a prescribed dose of 60.7 +/- 4.3 Gy to the target, the additional 5 Gy increasing the TCP from 53.1 +/- 5.5 to 68.9 +/- 4.1%. When the spinal cord tolerance was raised from 45 to 48 Gy, technique CF3 allowed 63.6 +/- 4.1 Gy to be delivered to the target, thereby increasing the TCP to 78.1 +/- 3.2%. Conclusions: Conformal radiotherapy techniques offer the potential for a 5-10 Gy escalation in dose delivered to the oesophagus, without increasing the mean lung dose. This is expected to increase local tumour control by 15-25%. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:183 / 193
页数:11
相关论文
共 50 条
  • [31] 3D conformal radiotherapy for malignant astrocytomas: Dose escalation to 90 Gy
    Radany, EH
    Sandler, HM
    TenHaken, RK
    Marsh, LH
    Parker, P
    Greenberg, HS
    Junck, L
    Page, M
    Lichter, AS
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 140 - 140
  • [32] Multicentre conformal radiotherapy dose escalation study for the treatment of localized prostate cancer. Preliminary evaluation of safety and quality of life. Commentary
    Hubert, J
    PROGRES EN UROLOGIE, 2001, 11 (02): : 275 - 275
  • [33] Dose escalation with 3D-CRT in prostate cancer: French study of dose escalation with conformal 3D radiotherapy in prostate cancer - Preliminary results
    Bey, P
    Carrie, C
    Beckendorf, V
    Ginestet, C
    Aletti, P
    Madelis, G
    Luporsi, E
    Pommier, P
    Cowen, D
    Gonzague-Casabianca, L
    Simonian-Sauve, M
    Maingon, P
    Naudy, S
    Lagrange, JL
    Marcie, S
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (02): : 513 - 517
  • [34] Three-dimensional conformal radiotherapy in localized carcinoma of prostate: preliminary reports of toxicity in dose-escalation treatment
    Tumminello, E.
    La Paglia, L.
    Montemaggi, P.
    UROLOGIA JOURNAL, 2007, 74 (02) : 107 - 112
  • [35] Automatic Planning as a Potential Strategy for Dose Escalation for Pancreas SBRT?
    Wang, S.
    Zheng, D.
    Ma, R.
    Lin, C.
    Zhu, X.
    Lei, Y.
    Enke, C.
    Zhou, S.
    MEDICAL PHYSICS, 2016, 43 (06) : 3319 - 3319
  • [36] Dose escalation with stereotactic body radiotherapy for cervical cancer treatment
    Turna, Menekse
    Rzazade, Rashad
    Kucukmorkoc, Esra
    Kucuk, Nadir
    Canoglu, Mehmet Dogu
    Caglar, Hale Basak
    BMC CANCER, 2024, 24 (01)
  • [37] Radiotherapy dose escalation using pre-treatment diffusion-weighted imaging in locally advanced rectal cancer: a planning study
    Hearn, Nathan
    Leppien, Alexandria
    O'Connor, Patrick
    Cahill, Katelyn
    Atwell, Daisy
    Vignarajah, Dinesh
    Min, Myo
    BJR OPEN, 2023, 6 (01):
  • [38] PHASE III PILOT STUDY OF DOSE ESCALATION USING CONFORMAL RADIOTHERAPY IN PROSTATE CANCER: LONG TERM FOLLOW UP
    Creak, A.
    Hall, E.
    Horwich, A.
    Eeles, R.
    Huddart, R.
    Dearnaley, D. P.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S201 - S201
  • [39] Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects
    Dearnaley, DP
    Hall, E
    Lawrence, D
    Huddart, RA
    Eeles, R
    Nutting, CM
    Gadd, J
    Warrington, A
    Bidmead, M
    Horwich, A
    BRITISH JOURNAL OF CANCER, 2005, 92 (03) : 488 - 498
  • [40] Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects
    D P Dearnaley
    E Hall
    D Lawrence
    R A Huddart
    R Eeles
    C M Nutting
    J Gadd
    A Warrington
    M Bidmead
    A Horwich
    British Journal of Cancer, 2005, 92 : 488 - 498